Sharon Barbari has been a member of the company’s board of directors since January 2019. Ms. Barbari has over 40 years of pharmaceutical and biotechnology experience. From 2004 to 2017, she was Chief Financial Officer at Cytokinetics. Ms. Barbari spent 4 years from 1998 to 2002 in senior financial roles at Gilead Sciences, including CFO. In this position, she led the finance, accounting, and information technology functions during a period of significant growth for Gilead. Ms. Barbari was also employed as CFO and Senior Vice President of Finance and Administration at InterMune, and Vice President of Strategic Planning at Foote, Cone & Belding Healthcare. She began her career at Syntex Corporation/Roche Pharmaceuticals, where she held various roles of increasing responsibility from 1972 to 1996. Ms. Barbari currently serves as a board member for Sonoma Pharmaceuticals, and as a board member for the Association of Bioscience Finance Officers. She previously was a board member for Phytogen Life Sciences. In 2017, Ms. Barbari was a recipient of the YWCA Silicon Valley Tribute to Women Awards. She received her BS in accounting from San Jose State University.